CETIRIZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cetirizine, and what generic alternatives are available?
Cetirizine is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Apozeal Pharms, Aurobindo Pharma Ltd, Bajaj, Bionpharma, Chartwell Molecular, Lannett Co Inc, Padagis Us, Pharm Assoc, Ranbaxy Labs Ltd, Rubicon Research, Taro, Teva Pharms, Time Cap Labs, Regcon Holdings, Apotex, Catalent, Onesource Specialty, Sun Pharm Inds Inc, Perrigo R And D, Aiping Pharm Inc, Amneal Pharms Ny, Apotex Inc, Cipla Ltd, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms, Granules, Heritage Pharma, Marksans Pharma, Mylan, Orbion Pharms, Pld Acquisitions, Sun Pharm Inds Ltd, Torrent Pharms Llc, Unichem, Unique, Ivax Sub Teva Pharms, and Ppi-dac. and is included in fifty-one NDAs.
The generic ingredient in CETIRIZINE is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetirizine
A generic version of CETIRIZINE was approved as cetirizine hydrochloride; pseudoephedrine hydrochloride by IVAX SUB TEVA PHARMS on February 25th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CETIRIZINE?
- What are the global sales for CETIRIZINE?
- What is Average Wholesale Price for CETIRIZINE?
Summary for CETIRIZINE
| US Patents: | 0 |
| Applicants: | 40 |
| NDAs: | 51 |
| Drug Prices: | Drug price information for CETIRIZINE |
| Drug Sales Revenues: | Drug sales revenues for CETIRIZINE |
| DailyMed Link: | CETIRIZINE at DailyMed |



